GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Cyclically Adjusted Revenue per Share

Embla Medical hf (OCSE:EMBLA) Cyclically Adjusted Revenue per Share : kr12.38 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Embla Medical hf's adjusted revenue per share for the three months ended in Mar. 2024 was kr3.154. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr12.38 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Embla Medical hf's average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Embla Medical hf was 12.70% per year. The lowest was 8.50% per year. And the median was 10.45% per year.

As of today (2024-05-26), Embla Medical hf's current stock price is kr28.50. Embla Medical hf's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr12.38. Embla Medical hf's Cyclically Adjusted PS Ratio of today is 2.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Embla Medical hf was 7.20. The lowest was 2.21. And the median was 4.53.


Embla Medical hf Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Embla Medical hf's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Cyclically Adjusted Revenue per Share Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.74 8.41 9.28 10.69 12.04

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.13 11.55 11.77 12.04 12.38

Competitive Comparison of Embla Medical hf's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted PS Ratio falls into.



Embla Medical hf Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Embla Medical hf's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.154/144.9095*144.9095
=3.154

Current CPI (Mar. 2024) = 144.9095.

Embla Medical hf Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.605 98.777 2.355
201409 1.609 98.734 2.361
201412 1.735 98.669 2.548
201503 1.761 99.612 2.562
201506 1.898 100.289 2.742
201509 1.687 100.607 2.430
201512 2.066 100.657 2.974
201603 1.721 101.115 2.466
201606 2.063 101.923 2.933
201609 1.954 102.457 2.764
201612 2.226 102.562 3.145
201703 2.102 102.768 2.964
201706 2.221 103.496 3.110
201709 2.012 103.871 2.807
201712 2.231 104.481 3.094
201803 2.017 105.600 2.768
201806 2.357 106.206 3.216
201809 2.157 106.727 2.929
201812 2.538 108.388 3.393
201903 2.590 108.702 3.453
201906 2.900 109.758 3.829
201909 2.771 109.922 3.653
201912 2.503 110.588 3.280
202003 2.657 111.019 3.468
202006 2.050 112.667 2.637
202009 2.637 113.772 3.359
202012 2.457 114.542 3.108
202103 2.438 115.833 3.050
202106 2.904 117.451 3.583
202109 2.793 118.723 3.409
202112 2.630 120.398 3.165
202203 2.884 123.555 3.382
202206 3.074 127.809 3.485
202209 3.144 129.810 3.510
202212 2.950 131.901 3.241
202303 3.111 135.674 3.323
202306 3.332 139.150 3.470
202309 3.202 140.147 3.311
202312 3.286 142.125 3.350
202403 3.154 144.910 3.154

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Embla Medical hf  (OCSE:EMBLA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Embla Medical hf's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=28.50/12.38
=2.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Embla Medical hf was 7.20. The lowest was 2.21. And the median was 4.53.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Embla Medical hf Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines